| PERIOD ENDING | 1-Nov-09 | 2-Aug-09 | 3-May-09 | 1-Feb-09 | | Total Revenue | 2,203,000 | 1,528,000 | 1,686,000 | 2,122,000 | | Cost of Revenue | 1,280,000 | 893,000 | 1,001,000 | 1,285,000 | | | Gross Profit | 923,000 | 635,000 | 685,000 | 837,000 | | | Operating Expenses | | Research Development | 29,000 | 31,000 | 27,000 | 27,000 | | Selling General and Administrative | 416,000 | 459,000 | 372,000 | 455,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 478,000 | 145,000 | 286,000 | 355,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,000 | 4,000 |
-
|
-
| | Earnings Before Interest And Taxes | 479,000 | 149,000 | 286,000 | 355,000 | | Interest Expense | 28,000 | 27,000 | 26,000 | 25,000 | | Income Before Tax | 451,000 | 122,000 | 260,000 | 330,000 | | Income Tax Expense | 147,000 | 53,000 | 86,000 | 101,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 304,000 | 69,000 | 174,000 | 229,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 4,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 304,000 | 69,000 | 174,000 | 233,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $304,000 | $69,000 | $174,000 | $233,000 |
|
0.03% Nasdaq 
Income Statement
